Treatments designed to help manage common skin conditions. You can access the Important Safety Information and Prescribing Information for each product by visiting the product websites linked below.
Important Safety Information for ACCUTANE® (ISOTRETINOIN CAPSULES USP)
What is the most important information I should know about Accutane?
Accutane is used to treat a type of severe acne (nodular acne) that has not been helped by other treatments, including antibiotics.
Accutane can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births. Patients who are pregnant or who plan to become pregnant must not take Accutane.
Please see additional Important Safety Information for Accutane below and the Medication Guide and full Prescribing Information for Boxed Warning, Contraindications, other important Warnings and Precautions, Drug Interactions, Use in Specific Populations, and Adverse Reactions.
Important Safety Information for ACCUTANE® (ISOTRETINOIN CAPSULES USP)
What is the most important information I should know about Accutane?
Accutane is used to treat a type of severe acne (nodular acne) that has not been helped by other treatments, including antibiotics.
Accutane can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births. Patients who are pregnant or who plan to become pregnant must not take Accutane.
Please see additional Important Safety Information for Accutane below and the Medication Guide and full Prescribing Information for Boxed Warning, Contraindications, other important Warnings and Precautions, Drug Interactions, Use in Specific Populations, and Adverse Reactions.
Important Safety Information for ACCUTANE® (ISOTRETINOIN CAPSULES USP)
What is the most important information I should know about Accutane?
Accutane is used to treat a type of severe acne (nodular acne) that has not been helped by other treatments, including antibiotics.
Accutane can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births. Patients who are pregnant or who plan to become pregnant must not take Accutane.
Please see additional Important Safety Information for Accutane below and the Medication Guide and full Prescribing Information for Boxed Warning, Contraindications, other important Warnings and Precautions, Drug Interactions, Use in Specific Populations, and Adverse Reactions.
Important Safety Information for ACCUTANE® (ISOTRETINOIN CAPSULES USP)
What is the most important information I should know about Accutane?
Accutane is used to treat a type of severe acne (nodular acne) that has not been helped by other treatments, including antibiotics.
Accutane can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births. Patients who are pregnant or who plan to become pregnant must not take Accutane.
Please see additional Important Safety Information for Accutane below and the Medication Guide and full Prescribing Information for Boxed Warning, Contraindications, other important Warnings and Precautions, Drug Interactions, Use in Specific Populations, and Adverse Reactions.
You are encouraged to report all side effects or Adverse Drug Events (ADEs) of prescription drugs to the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088. You are also encouraged to report side effects or ADEs to our Drug Safety Department at 1-855-531-1859 with as much information as available. You may report Accutane® side effects or ADEs by calling the Accutane Medical Information line at 1-844-325-3350.
Eligible patients may qualify for reduced out-of-pocket costs through the Journey Total Access Program.
© 2026 Journey Medical Corporation. All rights reserved August 2026 JMC-M16-R03.
EMROSI is a prescription medicine used to treat adults with pimples and bumps (inflammatory lesions) caused by a condition called rosacea.
EMROSI should not be used for the treatment of infections. It is not known if EMROSI is safe and effective in children.
EMROSI is an extended-release capsule that contains minocycline, a tetracycline medicine. Tetracyclines, when taken by mouth, may cause serious side effects, including: serious skin or allergic reactions which can cause skin redness, rash, hives, sores in your mouth, or your skin blisters and peels; swelling of your face, eyes, lips, tongue, or throat; trouble swallowing or breathing; blood in your urine; fever, yellowing of the skin or the whites of your eyes (jaundice), dark colored urine; pain on the right side of the stomach area (abdominal pain); chest pain or abnormal heartbeats; swelling in your legs, ankles, and feet; diarrhea which may be caused by an infection that can cause watery or bloody stools; loss of appetite; tiredness; unexplained bleeding or bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness. Call your doctor right away if these side effects occur.
The most common side effects of EMROSI include stomach upset or burning (dyspepsia) after eating or drinking. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Journey Medical Corporation at 1-855-531-1859.
Please see full Prescribing Information, including Patient Product Information.
INDICATIONS AND USAGE:
For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.SUMMARY OF RISK INFORMATION FOR EURAX CREAM
CONTRAINDICATIONS:
Do not apply EURAX topically to patients who develop sensitivity, are allergic to it, or manifest a primary irritation response to topical medications.WARNINGS:
Discontinue treatment with this product if severe irritation or sensitization develops, and institute appropriate therapy.PRECAUTIONS:
Do not apply EURAX in the eyes or mouth because it may cause irritation. Do not apply on acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided. It is not known whether EURAX can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. EURAX should be given to a pregnant woman only if clearly needed.PRECAUTIONS:
Safety and effectiveness in pediatric patients have not been established. Clinical studies with EURAX did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects.ADVERSE REACTIONS:
Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients. This preparation is not for ophthalmic, oral, or intravaginal use.What is the most important information I should know about Accutane?
Accutane is used to treat a type of severe acne (nodular acne) that has not been helped by other treatments, including antibiotics.
Accutane can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births. Patients who are pregnant or who plan to become pregnant must not take Accutane.
Patient must not get pregnant:
If you get pregnant while taking Accutane, stop taking it right away and call your healthcare provider.
Accutane is only for patients who can understand and agree to follow all the instructions in the iPLEDGE® REMS. Patients taking Accutane must register in the iPLEDGE® Pregnancy Registry at 1-866-495-0654 or www.ipledgeprogram.com. See your healthcare provider for further information.
Accutane can cause serious mental health problems, including:
Stop Accutane and call your doctor right away if you or a family member notices that you have any of the following signs and symptoms of depression or psychosis:
After stopping Accutane, you may also need follow-up mental health care if you had any of these symptoms.
Who should not take Accutane?
What should I tell my doctor before taking Accutane?
Tell your doctor if you or a family member has any of the following health conditions:
Tell your doctor if you are pregnant or breastfeeding. Accutane must not be used by women who are pregnant or breastfeeding.
Tell your doctor about all of the medicines you take including prescription and non-prescription medicines, vitamins and herbal supplements. Accutane and certain other medicines can interact with each other, sometimes causing serious side effects. Especially tell your doctor if you take:
These medicines should not be used with Accutane unless your doctor tells you it is okay.
Know the medicines you take. Keep a list of them to show to your doctor and pharmacist. Do not take any new medicine without talking with your doctor.
What should I avoid while taking Accutane?
What are the possible side effects of Accutane?
The common, less serious side effects of Accutane include:
These are not all of the possible side effects of Accutane. Call your healthcare professional for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or JG Pharma, Inc. at 1-844-325-3350.
Click here to see the full Prescribing Information for Boxed Warning, Contraindications, other Important Warnings and Precautions, Drug Interactions, Use in Specific Populations, and other Adverse Reactions.
Important Safety Information
AMZEEQ is a topical foam that contains minocycline, a tetracycline medicine. It is not taken by mouth. However, tetracyclines, when taken by mouth (capsules or tablets), may cause serious side effects, including: diarrhea which may be caused by an infection and can cause watery or bloody stools; loss of appetite; tiredness; yellowing of your skin or eyes (jaundice); bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness; discoloration or darkening of your skin, scars, teeth, or gums. Call your doctor right away if these side effects occur.
The most common side effect of AMZEEQ is headache.
These are not all of the possible side effects with AMZEEQ. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Indication
AMZEEQ® (minocycline) topical foam, 4% is a prescription medicine used on the skin (topical) for the treatment of pimples and red bumps (non-nodular inflammatory lesions) of moderate to severe acne in patients 9 years of age and older.
AMZEEQ should not be used for the treatment of infections. It is not known if AMZEEQ is safe and effective in children under 9 years of age. AMZEEQ is for use on skin only (topical use). AMZEEQ is not for use in your mouth, eyes or vagina.
Please see full Prescribing Information and Patient Information.
ZILXI is a topical foam that contains minocycline, a tetracycline medicine. It is not taken by mouth. However, tetracyclines, when taken by mouth (capsules or tablets), may cause serious side effects, including: diarrhea which may be caused by an infection and can cause watery or bloody stools; loss of appetite; tiredness; yellowing of your skin or eyes (jaundice); bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness; discoloration or darkening of your skin, scars, teeth, or gums. Call your doctor right away if these side effects occur.
The most common side effect of ZILXI is diarrhea.
These are not all of the possible side effects with ZILXI. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Patient Information.
ZILXI® (minocycline) topical foam, 1.5% is a prescription medicine used on the skin (topical) to treat adults with pimples and bumps caused by a condition called rosacea.
ZILXI should not be used for the treatment of infections. It is not known if ZILXI is safe and effective in children. ZILXI is for use on the skin only (topical use). ZILXI is not for use in your mouth, eyes or vagina.
Luxamend® is indicated for use in:
Luxamend is contraindicated for use:
Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of medical products to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for Full Prescribing Information.
INDICATIONS AND USAGE: EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are antifungal agents indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis,* and for the treatment of tinea versicolor. *Efficacy for this organism in the organ system was studied in fewer than 10 infections. EXELDERM® Cream is also indicated for the treatment of tinea pedis (athlete’s foot). Effectiveness of EXELDERM® Solution has not been proven in tinea pedis.
SUMMARY OF RISK INFORMATION FOR EXELDERM® CREAM AND SOLUTION
CONTRAINDICATIONS: EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are contraindicated in patients who have a history of hypersensitivity to any of its ingredients.
PRECAUTIONS: Use EXELDERM® (sulconazole nitrate) Cream and Solution, as directed by your physician only. EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are for external use only. Avoid contact with the eyes. If irritation develops, the cream or solution should be discontinued and appropriate therapy instituted.
There are no adequate and well-controlled studies in pregnant women. Sulconazole nitrate should be used during pregnancy only if clearly needed. Sulconazole nitrate has been shown to be embryotoxic in rats when given in doses of 125 times the adult human dose (in mg/kg). The drug was not teratogenic in rats or rabbits at oral doses of 50 mg/kg/day. Sulconazole nitrate given orally to rats at a dose 125 times the human dose resulted in prolonged gestation and dystocia. Several females died during the prenatal period, most likely due to labor complications.
It is not known whether sulconazole nitrate is excreted in human milk. Caution should be exercised when sulconazole nitrate is administered to a nursing woman.
Safety and effectiveness in children have not been established.
ADVERSE REACTIONS: There were no systemic effects and only infrequent cutaneous adverse reactions in 1185 patients treated with sulconazole nitrate cream in controlled clinical trials. Approximately 3% of these patients reported itching, 3% burning or stinging, and 1% redness. These complaints did not usually interfere with treatment.
There were no systemic effects and only infrequent cutaneous adverse reactions in 370 patients treated with sulconazole nitrate solution in controlled clinical trials. Approximately 1% of these patients reported itching and 1% burning or stinging. These complaints did not usually interfere with treatment.
These preparations are not for ophthalmic, oral, or intravaginal use.
For topical use only. Please see Full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
INDICATIONS AND USAGE:
EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are antifungal agents indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis,* and for the treatment of tinea versicolor.
*Efficacy for this organism in the organ system was studied in fewer than 10 infections. EXELDERM® Cream is also indicated for the treatment of tinea pedis (athlete’s foot). Effectiveness of EXELDERM® Solution has not been proven in tinea pedis.
SUMMARY OF RISK INFORMATION FOR EXELDERM® CREAM AND SOLUTION
CONTRAINDICATIONS: EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are contraindicated in patients who have a history of hypersensitivity to any of its ingredients.
PRECAUTIONS: Use EXELDERM® (sulconazole nitrate) Cream and Solution as directed by your physician only. These products are for external use only. Avoid contact with the eyes. If irritation develops, discontinue use and initiate appropriate therapy.
There are no adequate and well-controlled studies in pregnant women. Sulconazole nitrate should be used during pregnancy only if clearly needed. Sulconazole nitrate has been shown to be embryotoxic in rats at high doses. The drug was not teratogenic in rats or rabbits at oral doses of 50 mg/kg/day. High-dose exposure resulted in prolonged gestation and labor complications.
It is not known whether sulconazole nitrate is excreted in human milk. Caution should be exercised when administered to a nursing woman.
Safety and effectiveness in children have not been established.
ADVERSE REACTIONS: There were no systemic effects and only infrequent cutaneous adverse reactions in 1185 patients treated with sulconazole nitrate cream. Approximately 3% reported itching, 3% burning or stinging, and 1% redness. These complaints did not usually interfere with treatment.
There were no systemic effects and only infrequent cutaneous adverse reactions in 370 patients treated with sulconazole nitrate solution. Approximately 1% reported itching and 1% burning or stinging. These complaints did not usually interfere with treatment.
These preparations are not for ophthalmic, oral, or intravaginal use.
For topical use only. Please see Full Prescribing Information .
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088 .
TARGADOX® (doxycycline hyclate tablets) is a tetracycline-class antimicrobial indicated as adjunctive therapy for severe acne. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of TARGADOX and other antibacterial drugs, TARGADOX should be used only as indicated. The usual dose of oral doxycycline is 200mg on the first day of treatment (administered 100mg every 12 hours), followed by a maintenance dose of 100mg daily. There are no adequate and well-controlled studies on the use of doxycycline in pregnant women.
This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.
You are encouraged to report negative side effects of prescription drugs to Journey Medical Corp. at 1-855-531-1859 or the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for Full Prescribing Information.